Celltrion Usa
UEI: KY2GUQWZ4L87
• CAGE: 8DHW3
Overview
Parent Awardee
Company Description
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea.
Name
Celltrion Usa
Headquarters
Jersey City, NJ
United States
United States
Most Recent Award
Dec. 7, 2022
Calculating
Federal contract recipient
CELLTRION USA INC
(UEI KY2GUQWZ4L87, CAGE 8DHW3)
is headquartered in Jersey City NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in July 2018 and
federally registered in
August 2019.
Federal Award Analysis
Celltrion Usa federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CELLTRION USA INC
UEI
KY2GUQWZ4L87
CAGE Code
8DHW3
Primary NAICS
SBA Certifications
None
Self Certifications
Minority Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 26, 2018
Initial Registration
Aug. 23, 2019
Last Registration
Nov. 20, 2024
Registration Activation
Nov. 20, 2024
Registration Expiration
Nov. 13, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Celltrion Usa
GSA Schedules and Price Lists
- Celltrion Usa
- PoP: 4/14/20 - 4/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Celltrion Usa
- PoP: 11/1/19 - 4/15/20 (Ended)